![Niklas Axelsson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Niklas Axelsson
No open positions remaining
Net worth: 540 $ as of 31/07/2026
Profile
Mr. Niklas Axelsson was previously employed as a Chief Financial Officer by Diamyd Medical AB and a Chief Financial Officer by Sprint Bioscience AB. He received his undergraduate degree from Stockholm School of Economics.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 31/08/2025 | 5,000 ( 0% ) | 540 $ | 31/07/2026 |
Former positions of Niklas Axelsson
| Companies | Position | End |
|---|---|---|
| DIAMYD MEDICAL AB | Director of Finance/CFO | 01/07/2026 |
| SPRINT BIOSCIENCE AB | Director of Finance/CFO | - |
Training of Niklas Axelsson
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1
1st degree connections
3
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Stockholm School of Economics
 Stockholm School of Economics Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sprint Bioscience AB
 Sprint Bioscience AB Pharmaceuticals: MajorHealth Technology Develops medicines in the field of cancer and metabolism | Health Technology |
Diamyd Medical AB
 Diamyd Medical AB Pharmaceuticals: MajorHealth Technology Develops precision medicine drugs for type 1 diabetes and other forms of autoimmune diabetes | Health Technology |
- Stock Market
- Insiders
- Niklas Axelsson
